PsychonautWiki Archive

2C-T-2: Difference between revisions

← Older edit
>David Hedlund
{{DangerousInteractions/2C-T-x}}
>Apatheist
m Grammatics
 
(11 intermediate revisions by 5 users not shown)
Line 5: Line 5:
It is a member of the [[2C-x family]] of psychedelic phenethylamines, all of which were derived from the systematic modification of the [[mescaline]] molecule.  
It is a member of the [[2C-x family]] of psychedelic phenethylamines, all of which were derived from the systematic modification of the [[mescaline]] molecule.  


2C-T-2 was first synthesized and tested for activity in humans by [[Alexander Shulgin]] in 1981<ref>Shulgin, Alexander. "Pharmacology Lab Notes #4". Lafayette, CA. (1981-1982). p474 (Erowid.org) | https://erowid.org/library/books_online/shulgin_labbooks/shulgin_pharmacology_notebook4_searchable.pdf</ref> and described in his 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref name="pihkal2CT2">Shulgin, A., & Shulgin, A. (1991).
2C-T-2 was first synthesized and tested for activity in humans by [[Alexander Shulgin]] in 1981<ref name="Shulgin1982">{{cite book|author=Alexander Shulgin|author-link=Alexander Shulgin|title=Pharmacology Notes IV (The Shulgin Lab Books)|publisher=Erowid|url=https://erowid.org/library/books_online/shulgin_labbooks/shulgin_pharmacology_notebook4_searchable.pdf|page=474|place=Lafayette, CA, USA|year=1982}}</ref> and described in his 1991 book [[PiHKAL]] ("Phenethylamines I Have Known and Loved").<ref name="PiHKAL">{{cite book|title=PiHKAL: A Chemical Love Story|title-link=PiHKAL|author-link1=Alexander Shulgin|author1=Alexander Shulgin|author2=Ann Shulgin|year=1991|publisher=Transform Press|location=United States|isbn=0963009605|oclc=1166889264|chapter-url=https://erowid.org/library/books_online/pihkal/pihkal040.shtml|chapter=#40. 2C-T-2}}</ref> It is a member of the so-called "magical half-dozen" which refers to Shulgin's self-rated most important [[phenethylamine]]-derived compounds, all of which except [[mescaline]] he developed and synthesized himself. They are found within the first book of [[PiHKAL]], and are as follows: [[mescaline]], [[DOM]], [[2C-B]], 2C-E, [[2C-T-2]] and [[2C-T-7]].<ref>{{cite book|title=PiHKAL: A Chemical Love Story|author-link1=Alexander Shulgin|author1=Alexander Shulgin|author2=Ann Shulgin|year=1991|publisher=Transform Press|location=United States|isbn=0963009605|oclc=1166889264|url=https://erowid.org/library/books_online/pihkal/pihkal.shtml}}</ref>
[http://isomerdesign.com/PiHKAL/read.php?id=33 IsomerDesign: "PiHKAL" - #33 - 2C-I]. Retrieved Jan 22, 2018.</ref> It is a member of the so-called "magical half-dozen" which refers to Shulgin's self-rated most important [[phenethylamine]]-derived compounds, all of which except [[mescaline]] he developed and synthesized himself. They are found within the first book of [[PiHKAL]], and are as follows: [[mescaline]], [[DOM]], [[2C-B]], 2C-E, [[2C-T-2]] and [[2C-T-7]].<ref name="pihkalweb">Shulgin, A., & Shulgin, A. (1991). [https://www.erowid.org/library/books_online/pihkal/pihkal.shtml Erowid Online Books: "PIHKAL" - The Chemical Story]. Retrieved April 14, 2017.</ref>


Anecdotal reports generally characterize 2C-T-2 as a highly dose sensitive psychedelic known for its open headspace and unpredictable [[body load]].  
Anecdotal reports generally characterize 2C-T-2 as a highly dose sensitive psychedelic known for its open headspace and unpredictable [[body load]].  


Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has little history of human usage. Many reports also indicate that its physical effects may be too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions. It is highly advised to approach this [[hallucinogenic]] substance with the proper amount of precaution and [[harm reduction practices]] if using it.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-2, and it has a relatively short history of human usage. Many reports also indicate that its physical effects may be too severe for those who are not already experienced with [[psychedelics]] or suffer from pre-existing physical conditions. It is highly advised to approach this [[hallucinogenic]] substance with the proper amount of precaution and [[harm reduction practices]] if using it.


==History and culture==
==History and culture==
{{historyStub}}
{{historyStub}}
Following the initial positive results found by Shulgin's research group, a more formal study was carried out by psychedelic psychotherapy pioneer Myron J. Stolaroff who was interested in evaluating the potential use of 2C-T-2 in psychotherapy.<ref>Stolaroff, MJ; Wells, C. Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7. In Jahrbuch für Ethnomedizin und Bewußtseinsforschung (Yearbook of Ethnomedicine and the Study of Consciousness); Rätsch, C; Baker, J, Eds., 1993; Vol. 2, pp 99–117. (MAPS.org) | http://www.maps.org/images/pdf/1993_stolaroff_1.pdf</ref> Based on the experiences of forty participants in the study who took 2C-T-2, Stolaroff compared the effects favorably to [[MDMA]], describing it as more emotionally opening and permitting a wider exploration of feelings and thoughts.
Following the initial positive results found by Shulgin's research group, a more formal study was carried out by psychedelic psychotherapy pioneer Myron J. Stolaroff who was interested in evaluating the potential use of 2C-T-2 in psychotherapy.<ref>{{cite book|last1=Stolaroff|first1=M. J.|last2=Wells|first2=C.|chapter=Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7|title=Jahrbuch für Ethnomedizin und Bewußtseinsforschung|trans-title=Yearbook of Ethnomedicine and the Study of Consciousness|editor-last1=Rätsch|editor-first1=C.|editor-last2=Baker|editor-first2=J.|year=1993|volume=2|pages=99–117|publisher=Multidisciplinary Association for Psychedelic Studies (MAPS)|chapter-url=http://www.maps.org/images/pdf/1993_stolaroff_1.pdf}}</ref> Based on the experiences of forty participants in the study who took 2C-T-2, Stolaroff compared the effects favorably to [[MDMA]], describing it as more emotionally opening and permitting a wider exploration of feelings and thoughts.


==Chemistry==
==Chemistry==
Line 20: Line 19:
2C-T-2, or 2,5-dimethoxy-4-ethylthiophenethylamine, is a substituted [[phenethylamines|phenethylamine]] featuring a phenyl ring bound to an amino (NH<sub>2</sub>) group through an ethyl chain. 2C-T-2 belongs to the 2C family of phenethylamines which contain methoxy functional groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> of the benzene ring. 2C-T-2 is also substituted at R<sub>4</sub> with an ethyl thioether group.  
2C-T-2, or 2,5-dimethoxy-4-ethylthiophenethylamine, is a substituted [[phenethylamines|phenethylamine]] featuring a phenyl ring bound to an amino (NH<sub>2</sub>) group through an ethyl chain. 2C-T-2 belongs to the 2C family of phenethylamines which contain methoxy functional groups CH<sub>3</sub>O- attached to carbons R<sub>2</sub> and R<sub>5</sub> of the benzene ring. 2C-T-2 is also substituted at R<sub>4</sub> with an ethyl thioether group.  


2C-T-2 is a close structural analogue of [[2C-T-7]]; the two differ by the length of the alkane chain in their thioether functional group.<ref>http://isomerdesign.com/PiHKAL/read.php?id=40</ref>
2C-T-2 is a close structural analogue of [[2C-T-7]]; the two differ by the length of the alkane chain in their thioether functional group.<ref name ="PiHKAL"/>


==Pharmacology==
==Pharmacology==
Line 26: Line 25:
The mechanism of action that produces 2C-T-2’s [[hallucinogenic]] and [[entheogen]]ic effects has not been established in scientific literature; however, its primary psychedelic effects are more than likely a result of its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. This mechanism of action is shared by many other psychedelic [[phenethylamine]]s and [[tryptamine]]s.  
The mechanism of action that produces 2C-T-2’s [[hallucinogenic]] and [[entheogen]]ic effects has not been established in scientific literature; however, its primary psychedelic effects are more than likely a result of its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. This mechanism of action is shared by many other psychedelic [[phenethylamine]]s and [[tryptamine]]s.  


Athough no established scientific experiments have been performed to establish MAO-A inhibition of 2C-T-2, phenethylamine derivatives substituted with an alkylthio group at the 4 position (4-MTA, and the 2,5-desmethoxy derivative of [[2C-T-7]]) are known to act as selective [[MAOI|monoamine oxidase A inhibitors]].{{citation needed}} Furthermore, many compounds of the amphetamine-analogs of the [[2C-T-x]] have been found to have highly selective MAO-A inhibition<ref>https://www.ncbi.nlm.nih.gov/pubmed/15801832</ref><ref>http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.689.281&rep=rep1&type=pdf</ref>. Therefore, this substance may likewise have [[MAOI]] effects.<ref>http://www.sciencedirect.com/science/article/pii/S0006295206005971</ref>
Athough no established scientific experiments have been performed to establish MAO-A inhibition of 2C-T-2, phenethylamine derivatives substituted with an alkylthio group at the 4 position (4-MTA, and the 2,5-desmethoxy derivative of [[2C-T-7]]) are known to act as selective [[MAOI|monoamine oxidase A inhibitors]].{{citation needed}} Furthermore, many compounds of the amphetamine-analogs of the [[2C-T-x]] have been found to have highly selective MAO-A inhibition<ref name="Gallardo-Godoy2005">{{cite journal|title=Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling|doi=10.1021/jm0493109|pmid=15801832|first1=A.|last1=Gallardo-Godoy|first2=A.|last2=Fierro|first3=T. H.|last3=McLean|first4=M.|last4=Castillo|first5=B. K.|last5=Cassels|first6=M.|last6=Reyes-Parada|first7=D. E.|last7=Nichols|author-link7=David E. Nichols|year=2005|volume=48|issue=7|pages=2407–2419|journal=Journal of Medicinal Chemistry|issn=0022-2623|eissn=1520-4804|oclc=39480771|url=http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.689.281&rep=rep1&type=pdf}}</ref>. Therefore, this substance may likewise have [[MAOI]] effects.<ref>{{cite journal|title=Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series)|first1=D. S.|last1=Theobald|first2=H. H.|last2=Maurer|pmid=17067556|doi=10.1016/j.bcp.2006.09.022|journal=Biochemical Pharmacology|volume=73|issue=2|year=2007|pages=287-297|issn=0006-2952|eissn=1873-2968|oclc=01536391}}</ref>


However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
Line 121: Line 120:


===Dependence and abuse potential===
===Dependence and abuse potential===
2C-T-2 is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating.  
2C-T-2 is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating.  


Tolerance to the effects of 2C-T-2 are built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-T-2 presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-T-2 all psychedelics will have a reduced effect.
Tolerance to the effects of 2C-T-2 is built [[Time to full tolerance::almost immediately after ingestion]]. After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption). 2C-T-2 presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 2C-T-2 all psychedelics will have a reduced effect.


===Dangerous interactions===
===Dangerous interactions===
{{DangerousInteractions/Intro}}
{{DangerousInteractions/Intro}}


If 2C-T-2 does have [[MAOI]] effects as has been speculated,{{citation needed}} this could indicate that 2C-T-2 is more likely to induce [[serotonin syndrome]] or general [[neurotransmitter]] overload (especially at high dosages) than other [[serotonergic psychedelic|serotonergic psychedelics]].<ref>Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling | http://pubs.acs.org/doi/abs/10.1021/jm0493109</ref> This may make it dangerous to combine it with other [[MAOIs]], [[stimulant]]s and certain substances which promotes the release of neurotransmitters such as [[serotonin]] or [[dopamine]]. These substances include but are not limited to:
If 2C-T-2 does have [[MAOI]] effects as has been speculated,{{citation needed}} this could indicate that 2C-T-2 is more likely to induce [[serotonin syndrome]] or general [[neurotransmitter]] overload (especially at high dosages) than other [[serotonergic psychedelic|serotonergic psychedelics]].<ref name="Gallardo-Godoy2005"/> This may make it dangerous to combine it with other [[MAOIs]], [[stimulant]]s and certain substances which promotes the release of neurotransmitters such as [[serotonin]] or [[dopamine]]. These substances include but are not limited to:
{{DangerousInteractions/2C-T-x}}
{|
|-
|
*'''[[5-MeO-MiPT]]'''
*'''[[2C-T-7]]'''
*'''[[AMT]]'''
*'''[[Ayahuasca]]'''
*'''[[Harmala alkaloids]]'''
*'''[[2-AI]]'''
*'''[[2-FMA]]'''
*'''[[3-FPM]]'''
*'''[[4-FA]]'''
*'''[[A-PVP]]'''
*'''[[Amphetamine]]'''
*'''[[Cocaine]]'''
*'''[[Ethylphenidate]]'''
||
*'''[[N-Methylbisfluoromodafinil]]'''
*'''[[Isopropylphenidate]]'''
*'''[[MDAI]]'''
*'''[[MDMA]]'''
*'''[[Mephedrone]]'''
*'''[[Methamphetamine]]'''
*'''[[Methiopropamine]]'''
*'''[[Methylone]]'''
*'''[[Methylphenidate]]'''
*'''[[Modafinil]]'''
*'''[[Nicotine]]'''
*'''[[NM-2-AI]]'''
*'''[[Noopept]]'''
|}


==Legal status==
==Legal status==
*'''Australia:''' 2C-T-2 is illegal in Australia as of 2005.{{citation needed}}
In November 2003, the European Council decided that 2C-T-2 shall be subjected by the Member States to control measures and criminal penalties within three months.<ref>{{cite magazine|url=http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:321:0064:0065:EN:PDF|title=COUNCIL DECISION 2003/847/JHA|date=November 27, 2003|publication-date=December 6, 2003|work=Official Journal of the European Union|pages=64-65|id=L 321|publisher=Office for Official Publications of the European Communites|oclc=52224955}}</ref>
*'''Austria:''' 2C-T-2 is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).{{citation needed}}
 
*'''Belgium:''' 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004.{{citation needed}}
*'''Australia''': 2C-T-2 is illegal in Australia as of 2005.{{citation needed}}
*'''Brazil:''' 2C-T-2 is illegal to possess, produce and sell as it is listed on Portaria SVS/MS nº 344.<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref>
*'''Austria''': 2C-T-2 is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).{{citation needed}}
*'''Canada:''' 2C-T-2 would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref>
*'''Belgium''': 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004.{{citation needed}}
*'''China:''' As of October 2015, 2C-T-2 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
*'''Brazil''': 2C-T-2 is illegal to possess, produce and sell as it is listed on Portaria SVS/MS nº 344.<ref>{{cite web|url=http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7|title=RESOLUÇÃO DA DIRETORIA COLEGIADA - RDC N° 130, DE 2 DE DEZEMBRO DE 2016|publication-date=December 5, 2016|publisher=Agência Nacional de Vigilância Sanitária (ANVISA) [Brazilian Health Regulatory Agency (ANVISA)]|language=pt}}</ref>
*'''Denmark:''' 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.<ref>https://www.riigiteataja.ee/aktilisa/1090/2201/1004/109022011004Lisa1.pdf</ref>
*'''Canada''': 2C-T-2 would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>{{cite web|url=http://isomerdesign.com/Cdsa/schedule.php?schedule=3&section=ALL&structure=C|title=Schedule III|work=Controlled Drugs and Substances Act (CDSA)|publisher=Isomer Design|access-date=October 10, 2020}}</ref>
*'''European Union:''' The EU Council published an order on Dec 6, 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2.{{citation needed}}
*'''China''': As of October 2015, 2C-T-2 is a controlled substance in China.<ref>{{cite web|url=http://www.sfda.gov.cn/WS01/CL0056/130753.html|title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|publisher=国家食品药品监督管理总局 [China Food and Drug Administration (CFDA)]|date=September 27, 2015|language=zh|archive-url=https://web.archive.org/web/20170906191704/http://www.sfda.gov.cn/WS01/CL0056/130753.html|archive-date=September 6, 2017}}</ref>
*'''Germany:''' 2C-T-2 is illegal to possess, produce and sell.<ref>BtMG Anlage I | https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref>
*'''Denmark''': 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.<ref>{{cite web|url=https://www.riigiteataja.ee/aktilisa/1090/2201/1004/109022011004Lisa1.pdf|language=et|page=1|title=I Nimekiri}}</ref>{{Verify source|date=October 2020}}
*'''Italy:''' 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement.{{citation needed}}
*'''Germany''': 2C-T-2 is controlled under Anlage I BtMG (''Narcotics Act, Schedule I'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: Anlage I|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> as of October 10, 1998.<ref>{{cite web|url=http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl198s3126a.pdf|title=Zwölfte Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften|publisher=Bundesanzeiger Verlag|work=Bundesgesetzblatt Jahrgang 1998 Teil I Nr. 68|page=3126|publication-date=October 9, 1998|language=de|oclc=231871244|issn=0341-1095|date=October 7, 1998}}</ref> It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/__29.html|title=Gesetz über den Verkehr mit Betäubungsmitteln: § 29|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref>
*'''Japan:''' 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell.{{citation needed}}
*'''Italy''': 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement.{{citation needed}}
*'''Latvia:''' 2C-T-2 is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref>
*'''Japan''': 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell.{{citation needed}}
*'''Netherlands:''' 2C-T-2 was classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.{{citation needed}}
*'''Latvia''': 2C-T-2 is a Schedule I controlled substance.<ref>{{cite web|url=http://likumi.lv/doc.php?id=121086|title=Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem|publisher=VSIA Latvijas Vēstnesis|access-date=January 1, 2020|publication-date=November 10, 2005|language=lv}}</ref>
*'''Switzerland:''' 2C-T-2 is illegal to possess, produce and sell.<ref>http://web.archive.org/web/20170329020935/https://www.admin.ch/opc/de/classified-compilation/20101220/index.html</ref>
*'''The Netherlands''': 2C-T-2 was classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.{{citation needed}}
*'''United Kingdom:''' 2C-T-2 is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made</ref>
*'''Switzerland''': 2C-T-2 is a controlled substance specifically named under Verzeichnis D.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United States:''' 2C-T-2 is a Schedule 1 drug in the U.S., making it illegal to possess, manufacture, or import.{{citation needed}}
*'''United Kingdom''': 2C-T-2 is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.<ref>{{cite web|title=Schedule 2: Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=August 20, 2020|publisher=UK Government}}</ref>
*'''United States''': 2C-T-2 is a Schedule 1 drug in the U.S., making it illegal to possess, manufacture, or import.{{citation needed}}


==See also==
==See also==
Line 166: Line 196:
==References==
==References==
<references/>
<references/>
[[Category:Psychoactive substance]]
[[Category:Psychoactive substance]]
[[Category:Psychedelic]]
[[Category:2C-T-x]]
[[Category:Research chemical]]
[[Category:Research chemical]]
[[Category:Phenethylamine]]
[[Category:Psychedelic]]
[[Category:Hallucinogen]]


{{#set:Featured=true
{{#set:Featured=true
Retrieved from "http://psy.st/wiki/2C-T-2"